BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 21778572)

  • 1. Current treatment options in triple negative breast cancer.
    Rodler E; Korde L; Gralow J
    Breast Dis; 2010; 32(1-2):99-122. PubMed ID: 21778572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic triple-negative breast cancer.
    Rakha EA; Chan S
    Clin Oncol (R Coll Radiol); 2011 Nov; 23(9):587-600. PubMed ID: 21524569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic strategies for triple-negative breast cancer.
    Tan AR; Swain SM
    Cancer J; 2008; 14(6):343-51. PubMed ID: 19060597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Challenging clinical scenarios: treatment of patients with triple-negative or basal-like metastatic breast cancer.
    Greenberg S; Rugo HS
    Clin Breast Cancer; 2010 Sep; 10 Suppl 2():S20-9. PubMed ID: 20805062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promising therapeutic options in triple-negative breast cancer.
    Bilici A; Arslan C; Altundag K
    J BUON; 2012; 17(2):209-22. PubMed ID: 22740196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical trials in triple negative breast cancer.
    Reeder-Hayes KE; Carey LA; Sikov WM
    Breast Dis; 2010; 32(1-2):123-36. PubMed ID: 21778571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Triple-negative breast carcinoma--rewiev of current literature].
    Rubovszky G; Udvarhelyi N; Horváth Z; Láng I; Kásler M
    Magy Onkol; 2010 Dec; 54(4):325-35. PubMed ID: 21163763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Current status and future perspectives for the treatment of triple-negative breast cancer in Japan].
    Masuda N; Yasojima H; Mizutani M; Yamamura J
    Gan To Kagaku Ryoho; 2012 Apr; 39(4):512-8. PubMed ID: 22504674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of triple negative breast cancer (TNBC): current options and future perspectives.
    De Laurentiis M; Cianniello D; Caputo R; Stanzione B; Arpino G; Cinieri S; Lorusso V; De Placido S
    Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S80-6. PubMed ID: 21129616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular heterogeneity of triple-negative breast cancer and its clinical implications.
    Irshad S; Ellis P; Tutt A
    Curr Opin Oncol; 2011 Nov; 23(6):566-77. PubMed ID: 21986848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Updates in the treatment of basal/triple-negative breast cancer.
    Shastry M; Yardley DA
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):40-8. PubMed ID: 23222093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.
    Wang S; Yang H; Tong F; Zhang J; Yang D; Liu H; Cao Y; Liu P; Zhou P; Cheng L; Liu M; Guo J
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):255-8. PubMed ID: 19223741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Directed therapy of subtypes of triple-negative breast cancer.
    Carey LA
    Oncologist; 2011; 16 Suppl 1():71-8. PubMed ID: 21278443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible treatment strategies for triple-negative breast cancer on the basis of molecular characteristics.
    Kurebayashi J
    Breast Cancer; 2009; 16(4):275-80. PubMed ID: 19408071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of triple negative breast cancer.
    Oakman C; Viale G; Di Leo A
    Breast; 2010 Oct; 19(5):312-21. PubMed ID: 20382530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular profiling of triple negative breast cancer.
    Ma CX; Luo J; Ellis MJ
    Breast Dis; 2010; 32(1-2):73-84. PubMed ID: 21778575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Current data of targeted therapies for the treatment of triple-negative advanced breast cancer: empiricism or evidence-based?
    Petrelli F; Cabiddu M; Ghilardi M; Barni S
    Expert Opin Investig Drugs; 2009 Oct; 18(10):1467-77. PubMed ID: 19737114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-negative/basal-like breast cancer: clinical, pathologic and molecular features.
    Venkitaraman R
    Expert Rev Anticancer Ther; 2010 Feb; 10(2):199-207. PubMed ID: 20131996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triple negative breast cancer: a brief review of its characteristics and treatment options.
    Griffiths CL; Olin JL
    J Pharm Pract; 2012 Jun; 25(3):319-23. PubMed ID: 22551559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple-negative breast cancer: novel therapies and new directions.
    Pal SK; Mortimer J
    Maturitas; 2009 Aug; 63(4):269-74. PubMed ID: 19632796
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.